HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi Dai Selected Research

tPA stop

4/2007Tissue type plasminogen activator induced in rat dorsal horn astrocytes contributes to mechanical hypersensitivity following dorsal root injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi Dai Research Topics

Disease

31Neoplasms (Cancer)
05/2022 - 07/2008
31Pain (Aches)
04/2022 - 05/2003
27Hyperalgesia
01/2021 - 02/2001
23Inflammation (Inflammations)
01/2022 - 05/2003
19Osteoporosis
06/2021 - 11/2007
18Neuralgia (Stump Neuralgia)
05/2022 - 09/2002
15Hypersensitivity (Allergy)
04/2022 - 05/2003
12Endometriosis
04/2022 - 03/2007
12Hepatocellular Carcinoma (Hepatoma)
01/2022 - 06/2010
7Hypoxia (Hypoxemia)
01/2022 - 07/2011
7Peripheral Nerve Injuries
01/2016 - 02/2001
6Neoplasm Metastasis (Metastasis)
01/2021 - 01/2015
5Heart Failure
07/2022 - 07/2018
5Breast Neoplasms (Breast Cancer)
05/2022 - 01/2018
5Glaucoma
01/2022 - 01/2012
5Pelvic Pain
01/2022 - 03/2007
5Colitis
12/2020 - 01/2014
4Rare Diseases (Rare Disease)
10/2022 - 01/2021
4Fever (Fevers)
04/2022 - 10/2011
4Dysmenorrhea (Menstrual Pain)
01/2022 - 03/2007
4Dyspareunia
01/2022 - 03/2007
4Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
11/2021 - 11/2013
4Dehydration (Water Stress)
12/2020 - 04/2018
4Glioma (Gliomas)
02/2020 - 04/2013
3Gastroesophageal Reflux (GERD)
01/2022 - 01/2021
3Muscular Dystrophies (Muscular Dystrophy)
11/2021 - 01/2017
3Myocardial Infarction
11/2021 - 02/2019
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2020 - 11/2016
3Infections
04/2020 - 01/2008
3Encephalitis (Encephalitis, Rasmussen)
01/2020 - 02/2018
3Ulcerative Colitis
01/2020 - 01/2014
3Postmenopausal Osteoporosis
12/2016 - 08/2007
3Somatoform Disorders (Somatoform Disorder)
03/2016 - 01/2015
3Neurogenic Inflammation
11/2013 - 07/2007
3Cysts
09/2013 - 12/2008
3Constipation
02/2013 - 03/2007
3Acquired Immunodeficiency Syndrome (AIDS)
05/2011 - 10/2006
2Body Weight (Weight, Body)
05/2022 - 01/2022
2Dysbiosis
05/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

20Proteins (Proteins, Gene)FDA Link
03/2022 - 02/2001
13Capsules (Microcapsules)IBA
07/2022 - 06/2010
13Protein Kinases (Protein Kinase)IBA
08/2021 - 05/2003
12Pharmaceutical PreparationsIBA
10/2022 - 10/2006
10Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2017
9xian ling gu baoIBA
06/2021 - 01/2013
7CytokinesIBA
01/2022 - 03/2008
7p38 Mitogen-Activated Protein KinasesIBA
06/2008 - 11/2004
7Mitogen-Activated Protein KinasesIBA
05/2008 - 05/2003
6Retinaldehyde (Retinal)IBA
12/2021 - 02/2009
6LipidsIBA
06/2021 - 09/2010
6Adenosine Triphosphate (ATP)IBA
06/2019 - 09/2002
6OligodeoxyribonucleotidesIBA
06/2008 - 09/2005
56-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2022 - 03/2007
5Therapeutic UsesIBA
01/2022 - 02/2019
5Interleukin-6 (Interleukin 6)IBA
01/2022 - 10/2008
5Plant ExtractsIBA
12/2020 - 01/2013
5Messenger RNA (mRNA)IBA
02/2020 - 04/2002
5Nerve Growth Factor (NGF)IBA
03/2015 - 05/2003
4Dinoprostone (PGE2)FDA Link
01/2022 - 01/2018
4LigandsIBA
09/2021 - 08/2007
4Cisplatin (Platino)FDA LinkGeneric
06/2021 - 09/2012
4SteroidsIBA
02/2021 - 07/2008
4Peptides (Polypeptides)IBA
01/2021 - 04/2005
4EnzymesIBA
01/2021 - 04/2002
4Ion Channels (Ion Channel)IBA
01/2021 - 07/2006
4N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2020 - 01/2002
4Biological ProductsIBA
02/2019 - 01/2013
4MicroRNAs (MicroRNA)IBA
01/2019 - 04/2013
4Capsaicin (Zostrix)FDA Link
01/2016 - 09/2002
4Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
08/2012 - 03/2003
4U 0126 (UO 126)IBA
04/2008 - 09/2002
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2007 - 05/2003
3Reactive Oxygen Species (Oxygen Radicals)IBA
03/2022 - 01/2016
3Oxygen (Dioxygen)IBA
01/2022 - 01/2016
3InterleukinsIBA
01/2022 - 10/2008
3DystrophinIBA
11/2021 - 11/2013
3PlatinumIBA
06/2021 - 05/2011
3Glucose (Dextrose)FDA LinkGeneric
06/2021 - 01/2017
3AnkyrinsIBA
01/2021 - 06/2016
3Long Noncoding RNAIBA
01/2021 - 01/2016
3Sorafenib (BAY 43-9006)FDA Link
01/2021 - 12/2017
3TRPA1 Cation ChannelIBA
01/2021 - 05/2011
3TabletsIBA
01/2020 - 08/2007
3Circular RNAIBA
01/2019 - 01/2018
3FlavonoidsIBA
05/2018 - 08/2013
32,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA
01/2017 - 05/2008
3Peptide Hydrolases (Proteases)FDA Link
12/2016 - 05/2004
3Transient Receptor Potential ChannelsIBA
11/2013 - 11/2006
3SaponinsIBA
07/2013 - 03/2008
3Tryptases (Tryptase)IBA
08/2012 - 05/2004
3TrypsinIBA
08/2012 - 05/2004
3Freund's AdjuvantIBA
09/2007 - 05/2003
3Brain-Derived Neurotrophic Factor (BDNF)IBA
12/2004 - 05/2003

Therapy/Procedure

23Therapeutics
04/2022 - 05/2005
19Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2021 - 01/2013
7Drug Therapy (Chemotherapy)
03/2022 - 05/2011
6Ligation
01/2012 - 09/2002
4Cystectomy
01/2021 - 11/2019
3Injections
01/2016 - 04/2011
3Axotomy
01/2004 - 05/2003